Please Wait.....
Report
China Diabetes Market Report: 2024-2032
Market Report I 2024-07-01 I 131 Pages I IMARC Group
The China diabetes market size reached US$ 4.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 9.3 Billion by 2032, exhibiting a growth rate (CAGR) of 7.7% during 2024-2032.
China currently has the highest number of diabetics in the world. The disease has presently reached epidemic proportions in the adult population. Around three decades ago, less than one percent of the Chinese adult population had diabetes. These levels, however, have increased to around 12 percent - making it the diabetes capital of the world.
The rise of diabetes in China can be attributed to a number of factors. Driven by a strong economic growth over the past few decades, the Chinese population has become richer, fatter and less mobile. Apart from urbanisation and sedentary lifestyles, Chinese people are also genetically more vulnerable to diabetes compared to Europeans and many other population groups. Other factors such as poor awareness of health issues, high consumption of white rice, poor healthcare infrastructure, etc. have also driven the prevalence of the disease.
China's diabetes statistics may ring alarm bells for the government and healthcare authorities, for drug and diagnostic manufacturers, however, it represents a goldmine. Fuelled by a continuous increase in healthcare expenditures, the market for diabetes drugs and diagnostics is expanding robustly in the country. This is creating lucrative opportunities for global healthcare companies at a time when growth rates in the more developed markets have declined.
The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in China. The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the Chinese diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the China diabetes market in any form.
What we have achieved in this report:
Comprehensive situation analysis of the Chinese diabetes epidemiology and its dynamics:
Focus of the Analysis:
Historical, current and future prevalence of diabetes in China
Historical, current and future prevalence of type-1 and type-2 diabetes in China
Historical, current and future prevalence of diabetes in the urban and rural regions in China
Historical, current and future prevalence of diabetes among males and females in China
Historical, current and future prevalence of diabetes among various age groups in China
Historical, current and future diagnosis rates for diabetes in China
Historical, current and future drug treatment rates for diabetes in China
Comprehensive situation analysis of the Chinese Oral Antidiabetics market and its dynamics:
Focus of the Analysis:
Performance of the Oral Antidiabetics market in China
Performance of key classes
Performance of key players
Market outlook
Comprehensive situation analysis of the Chinese Insulin market and its dynamics:
Focus of the Analysis:
Performance of the Insulin market in China
Performance of key classes
Performance of key players
Market outlook
Comprehensive situation analysis of the Chinese diabetes diagnostics market and its dynamics:
Focus of the Analysis:
Performance of the diabetes diagnostics market in China
Market Segmentation
Key players
Market outlook
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Diabetes Disease Overview
5.1 What is Diabetes?
5.2 Diabetes Diagnosis and Treatment
5.2.1 Diagnosis
5.2.2 Treatment
5.3 Diabetes Complications
6 China Diabetes Epidemiology
6.1 Diabetes Population and Prevalence Rates
6.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
6.3 Population and Prevalence Rates by Region
6.4 Population and Prevalence Rates by Gender
6.5 Population and Prevalence Rates by Age Group
7 China Diabetes Market
7.1 Market Overview
7.2 Market Performance
7.3 Impact of COVID-19
7.4 Market Forecast
7.5 SWOT Analysis
7.5.1 Overview
7.5.2 Strengths
7.5.3 Weaknesses
7.5.4 Opportunities
7.5.5 Threats
7.6 Value Chain Analysis
7.7 Porter's Five Forces Analysis
7.7.1 Overview
7.7.2 Bargaining Power of Buyers
7.7.3 Bargaining Power of Suppliers
7.7.4 Degree of Competition
7.7.5 Threat of New Entrants
7.7.6 Threat of Substitutes
7.8 Market Breakup by Segment
7.8.1 China Oral Antidiabetics Market
7.8.1.1 Historical Market Trends
7.8.1.2 Market Breakup by Class
7.8.1.3 Market Shares of Key Players
7.8.1.4 Market Forecast
7.8.2 China Insulin Market
7.8.2.1 Historical Market Trends
7.8.2.2 Market Breakup by Class
7.8.2.3 Market Shares of Key Players
7.8.2.4 Market Forecast
8 Competitive Landscape
8.1 Competitive Structure
8.2 Profiles of Key Players
Figure 1: The Impact of Diabetes in the Human Body
Figure 2: Diabetes Complications
Figure 3: Global: Breakup of Diabetes Patients by Region, (in %) 2023 & 2032
Figure 4: Body Mass Index and Relative risk of Type-2 Diabetes
Figure 5: China: Total Number of Diabetes Patients (in 000), 2018-2023
Figure 6: China: Total Number of Diabetes Patients Forecast (in 000), 2024-2032
Figure 7: China (Type1 & Type2): Total Number of Diabetes Patients (in 000), 2018-2023
Figure 8: China (Type1 & Type2): Total Number of Diabetes Patients Forecast (in 000), 2024-2032
Figure 9: China (Urban & Rural): Total Number of Diabetes Patients (in 000), 2018-2023
Figure 10: China (Urban & Rural): Total Number of Diabetes Patients Forecast (in 000), 2024-2032
Figure 11: China (Male & Female): Total Number of Diabetes Patients (in 000), 2018-2023
Figure 12: China (Male & Female): Total Number of Diabetes Patients Forecast (in 000), 2024-2032
Figure 13: China: Total Number of Diabetes Patients by Age Group (20-39, 40-59, 60-79, (in 000), 2018-2023
Figure 14: China: Total Number of Diabetes Patients Forecast by Age Group (20-39, 40-59, 60-79, - in 000), 2024-2032
Figure 15: China: Diabetes Drug Industry Overview
Figure 16: China: Diabetes Drug Market: Sales Value (in Billion US$), 2018-2023
Figure 17: China: Diabetes Drug Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 18: China: Diabetes Drug Market: SWOT Analysis
Figure 19: China: Diabetes Drug Market: Value Chain Analysis
Figure 20: China: Diabetes Drug Market: Porters Five Forces Analysis
Figure 21: China: Diabetes Drug Market: Breakup of Insulin and Oral Antidiabetics (in %), 2018-2023
Figure 22: China: Diabetes Drug Market Forecast: Breakup of Insulin and Oral Antidiabetics (in %), 2024-2032
Figure 23: China: Oral Antidiabetics Market: Sales Value (in Million US$), 2018-2023
Figure 24: China: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2018 & 2023
Figure 25: China: Oral Anti-diabetics Market: Sales Share of Key Players (in %)
Figure 26: China: Oral Antidiabetics Market Forecast : Sales Value (in Million US$), 2024-2032
Figure 27: China: Insulin Market: Sales Value (in Million US$), 2018-2023
Figure 28: China: Breakup of Insulin Market by Class (in %), 2018 & 2023
Figure 29: China: Insulin Market: Sales Share of Key Players (in %)
Figure 30: China: Insulin Market Forecast: Sales Value (in Million US$), 2024-2032
Table 1: Diagnosis of Diabetes
Table 2: Global: Diabetes Population Breakup by Country (in 000's), 2023 and 2032
Table 3: China: Total Prevalence & Number of Diabetes Patients, 2018, 2023 & 2032
Table 4: China (Type1 & Type2): Total Prevalence & Number of Diabetes Patients, 2018, 2023 & 2032
Table 5: China (Urban & Rural): Total Prevalence & Number of Diabetes Patients, 2018, 2023 & 2032
Table 6: China (Male & Female): Total Prevalence & Number of Diabetes Patients, 2018, 2023 & 2032
Table 7: China: Total Prevalence & Number of Diabetes Patients by Age Group (20-39, 40-59, 60-79 - in 000), 2018, 2023 & 2032
Table 8: China: Diabetes Drug Market: Competitive Structure
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security